Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    September 2019
  1. YAMAGATA K, Yamori Y
    Inhibition of Endothelial Dysfunction by Dietary Flavonoids and Preventive Effects Against Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2019 Sep 21. doi: 10.1097/FJC.0000000000000757.
    PubMed     Text format     Abstract available


  2. YU Y, Sun J, Liu J, Wang P, et al
    Ginsenoside Re preserves cardiac function and ameliorates left ventricular remodeling in a rat model of myocardial infarction.
    J Cardiovasc Pharmacol. 2019 Sep 14. doi: 10.1097/FJC.0000000000000752.
    PubMed     Text format     Abstract available


  3. ABBATE A, Booz GW
    Cardiovascular Pharmacology of the NLRP3 Inflammasome.
    J Cardiovasc Pharmacol. 2019;74:173-174.
    PubMed     Text format    


    August 2019
  4. ZHANG J, Pan J, Yang M, Jin X, et al
    Up-regulating microRNA-203 alleviates myocardial remodeling and cell apoptosis through down-regulating PTP1B in rats with myocardial infarction.
    J Cardiovasc Pharmacol. 2019 Aug 10. doi: 10.1097/FJC.0000000000000733.
    PubMed     Text format     Abstract available


    July 2019
  5. GHAFFARZADEH A, Bagheri M, Khadem-Vatani K, Rad IA, et al
    Association of MMP-1 (rs1799750)-1607 2G/2G and MMP-3 (rs3025058)-1612 6A/6A genotypes with coronary artery disease risk among Iranian Turks.
    J Cardiovasc Pharmacol. 2019 Jul 25. doi: 10.1097/FJC.0000000000000727.
    PubMed     Text format     Abstract available


  6. ABBATE A, Booz GW
    Cardiovascular Pharmacology of the NLRP3 Inflammasome.
    J Cardiovasc Pharmacol. 2019 Jul 24. doi: 10.1097/FJC.0000000000000725.
    PubMed     Text format    


  7. LU S, Zhong J, Zhang Y, Huang K, et al
    CYP17A1 Polymorphisms are Linked to the Risk of Coronary Heart Disease in A Case-control Study.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000687.
    PubMed     Text format     Abstract available


  8. TAKAHASHI M
    Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000709.
    PubMed     Text format     Abstract available


  9. BUCKLEY LF, Libby P
    Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000701.
    PubMed     Text format     Abstract available


  10. TRANKLE C, Wohlford G, Buckley LF, Kadariya D, et al
    Alirocumab in Acute Myocardial Infarction: Results from the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000706.
    PubMed     Text format     Abstract available


  11. MARTON Z, Pataricza J, Pollesello P, Varro A, et al
    The novel inodilator ORM-3819 relaxes isolated porcine coronary arteries: role of voltage-gated potassium channels activation.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000700.
    PubMed     Text format     Abstract available


  12. LI YH, Yang SS, Guo XH, Chen YD, et al
    Prophylactic use of mucosal protective agents and proton pump inhibitors in patients undergoing percutaneous coronary intervention: real world evidences of 36870 patients.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000684.
    PubMed     Text format     Abstract available


  13. YAMAGATA K
    Soy isoflavones inhibit endothelial cell dysfunction and prevent cardiovascular disease.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000708.
    PubMed     Text format     Abstract available


  14. YANG JB, Kang YM, Zhang C, Yu XJ, et al
    Infusion of melatonin into the paraventricular nucleus ameliorates myocardial ischemia-reperfusion injury by regulating oxidative stress and inflammatory cytokines.
    J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000711.
    PubMed     Text format     Abstract available


  15. MAURO AG, Bonaventura A, Mezzaroma E, Quader M, et al
    The NLRP3 inflammasome in acute myocardial infarction.
    J Cardiovasc Pharmacol. 2019 Jul 12. doi: 10.1097/FJC.0000000000000717.
    PubMed     Text format     Abstract available


  16. JOOST VAN ESDONK M, Stevens J, Stuurman FE, de Boon WMI, et al
    The pharmacodynamic effects of a dopamine-somatostatin chimera agonist on the cardiovascular system.
    J Cardiovasc Pharmacol. 2019 Jul 11. doi: 10.1097/FJC.0000000000000695.
    PubMed     Text format     Abstract available


  17. YOSHIDA R, Ishii H, Morishima I, Tanaka A, et al
    Impact of Post-Discharge Bleeding on Long-Term Mortality in Percutaneous Coronary Intervention Patients Taking Oral Anticoagulants.
    J Cardiovasc Pharmacol. 2019 Jul 11. doi: 10.1097/FJC.0000000000000702.
    PubMed     Text format     Abstract available


  18. MISHRA A, Singh M, Acker WW, Kamboj S, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2019 Jul 11. doi: 10.1097/FJC.0000000000000697.
    PubMed     Text format     Abstract available


  19. WU J, Ye Y, Li C, Zhou W, et al
    Correlation of Inhaled Long-acting Bronchodilators with Adverse Cardiovascular Outcomes in Patients with Stable COPD: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.
    J Cardiovasc Pharmacol. 2019 Jul 11. doi: 10.1097/FJC.0000000000000705.
    PubMed     Text format     Abstract available


    May 2019
  20. PUCHULU MB, Arreche N, Zotta E, Donato M, et al
    Erythropoietin Improves Cardiovascular Function in Adult Rats After Acute Hemorrhage.
    J Cardiovasc Pharmacol. 2019;73:290-300.
    PubMed     Text format     Abstract available


  21. CHEN W, Chen XY, Wang Y, Wang HY, et al
    Mechanism of Emulsified Isoflurane Postconditioning-Induced Activation of the Nrf2-Antioxidant Response Element Signaling Pathway During Myocardial Ischemia-Reperfusion: The Relationship With Reactive Oxygen Species.
    J Cardiovasc Pharmacol. 2019;73:265-271.
    PubMed     Text format     Abstract available


    March 2019
  22. PUCHULU MB, Arreche N, Zotta E, Donato M, et al
    Erythropoietin improves cardiovascular function in adult rats after acute hemorrhage.
    J Cardiovasc Pharmacol. 2019 Mar 14. doi: 10.1097/FJC.0000000000000666.
    PubMed     Text format     Abstract available


  23. SALAH E, Bastacky SI, Jackson EK, Tofovic SP, et al
    2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury.
    J Cardiovasc Pharmacol. 2019;73:165-177.
    PubMed     Text format     Abstract available


    December 2018
  24. MOMCILOVIC S, Milovanovic JR, Jankovic SM, Jovanovic A, et al
    Population pharmacokinetic analysis of bisoprolol in patients with acute coronary syndrome.
    J Cardiovasc Pharmacol. 2018 Dec 10. doi: 10.1097/FJC.0000000000000644.
    PubMed     Text format     Abstract available


    November 2018
  25. LEENEN FH, Ahmad M, Marc Y, Llorens-Cortes C, et al
    Specific Inhibition of Brain Angiotensin III formation as a new strategy for prevention of heart failure after myocardial infarction.
    J Cardiovasc Pharmacol. 2018 Nov 30. doi: 10.1097/FJC.0000000000000638.
    PubMed     Text format     Abstract available


  26. LIU XW, Lu MK, Zhong HT, Wang LH, et al
    Panax Notoginseng Saponins Attenuate Myocardial Ischemia Reperfusion Injury via the HIF-1alpha/BNIP3 Pathway of Autophagy.
    J Cardiovasc Pharmacol. 2018 Nov 30. doi: 10.1097/FJC.0000000000000640.
    PubMed     Text format     Abstract available


  27. TIAN X, Zhou Y, Wang Y, Zhang S, et al
    Mitochondrial Dysfunction and Apoptosis are Attenuated upon kappa-Opioid Receptor Activation via AMPK/GSK-3beta Pathway Following Myocardial Ischemia and Reperfusion.
    J Cardiovasc Pharmacol. 2018 Nov 5. doi: 10.1097/FJC.0000000000000635.
    PubMed     Text format     Abstract available


    October 2018
  28. BOOZ GW
    Seizing the Future: What's next for the Journal of Cardiovascular Pharmacology?
    J Cardiovasc Pharmacol. 2018 Oct 30. doi: 10.1097/FJC.0000000000000630.
    PubMed     Text format    


  29. PIQUERAS-FLORES J, Jurado-Roman A, Lopez-Lluva MT, Sanchez-Perez I, et al
    Efficacy and safety of loading doses with P2Y12-receptor antagonists in patients without dual antiplatelet therapy undergoing elective coronary intervention.
    J Cardiovasc Pharmacol. 2018 Oct 30. doi: 10.1097/FJC.0000000000000632.
    PubMed     Text format     Abstract available


  30. YUAN L, Tang C, Li D, Yang Z, et al
    microRNA-18a expression in female coronary heart disease and regulatory mechanism on endothelial cell by targeting estrogen receptorsss.
    J Cardiovasc Pharmacol. 2018 Oct 24. doi: 10.1097/FJC.0000000000000623.
    PubMed     Text format     Abstract available


    June 2018
  31. DIMITROULIS D, Golabkesh M, Naguib D, Knoop B, et al
    Safety and efficacy in Prasugrel vs. Ticagrelor treated ST-elevation myocardial infarction (STEMI) patients.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000609.
    PubMed     Text format     Abstract available


  32. ZHOU L, Liu X, Wang ZQ, Li Y, et al
    Simvastatin Treatment Protects Myocardium in Non-coronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000611.
    PubMed     Text format     Abstract available


    May 2018
  33. VAN TAUNAY JS, Albelda MT, Frias JC, Lipinski MJ, et al
    Biologics and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000595.
    PubMed     Text format     Abstract available


    April 2018
  34. CHEN S, Zhang S, Luan H, Zeng X, et al
    Correlation Between Extended Leukocyte Differential Count and Coronary Artery Disease.
    J Cardiovasc Pharmacol. 2018 Apr 10. doi: 10.1097/FJC.0000000000000582.
    PubMed     Text format     Abstract available


  35. SALAH EM, Bastacky SI, Jackson EK, Tofovic SP, et al
    Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    J Cardiovasc Pharmacol. 2018;71:205-214.
    PubMed     Text format     Abstract available


    March 2018
  36. ABOUZAKI NA, Christopher S, Trankle C, Van Tassell BW, et al
    Inhibiting the inflammatory injury following myocardial ischemia reperfusion with plasma derived alpha-1 anti-trypsin: a post-hoc analysis of the VCU-alpha1RT study.
    J Cardiovasc Pharmacol. 2018 Mar 23. doi: 10.1097/FJC.0000000000000583.
    PubMed     Text format     Abstract available


  37. BISGAIER CL, Oniciu DC, Srivastava RAK
    Comparative Evaluation of Gemcabene and PPAR Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 Mar 21. doi: 10.1097/FJC.0000000000000580.
    PubMed     Text format     Abstract available


  38. MOHAMMAD FIC AM, Al-Allawi NA
    CYP2C19 genotype is an independent predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel Post Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2018 Mar 12. doi: 10.1097/FJC.0000000000000577.
    PubMed     Text format     Abstract available


  39. DARWESH AM, El-Azab MF, Abo-Gresha NM, El-Sayed NM, et al
    Cardioprotective Mechanisms of Exenatide in Isoprenaline-induced Myocardial Infarction: Novel Effects on Myocardial alpha-Estrogen Receptor Expression and IGF-1/IGF-2 System.
    J Cardiovasc Pharmacol. 2018;71:160-173.
    PubMed     Text format     Abstract available


    February 2018
  40. DUAN Q, Xu Y, Marck PV, Kalisz J, et al
    Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart.
    J Cardiovasc Pharmacol. 2018;71:95-103.
    PubMed     Text format     Abstract available


    January 2018
  41. SIGURDSSON MI, Waldron NH, Bortsov AV, Smith SB, et al
    Genomics of Cardiovascular Measures of Autonomic Tone.
    J Cardiovasc Pharmacol. 2018 Jan 3. doi: 10.1097/FJC.0000000000000559.
    PubMed     Text format     Abstract available


    December 2017
  42. ABBATE A
    Why the CANTOS Is a Game Changer in Cardiovascular Medicine.
    J Cardiovasc Pharmacol. 2017;70:353-355.
    PubMed     Text format    


    September 2017
  43. JAZMIN FM, Diana RH, Citali SH, Diego LM, et al
    Sex Differences In Vascular Reactivity To Angiotensin Ii During The Evolution Of Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Sep 29. doi: 10.1097/FJC.0000000000000542.
    PubMed     Text format     Abstract available


    June 2017
  44. ZHONG Y, Zhong P, He S, Zhang Y, et al
    Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
    J Cardiovasc Pharmacol. 2017;69:389-397.
    PubMed     Text format     Abstract available


    May 2017
  45. HARISSEH R, Chiari P, Villedieu C, Sueur P, et al
    Cyclophilin D Modulates the Cardiac Mitochondrial Target of Isoflurane, Sevoflurane, and Desflurane.
    J Cardiovasc Pharmacol. 2017;69:326-334.
    PubMed     Text format     Abstract available


  46. VECSERNYES M, Szokol M, Bombicz M, Priksz D, et al
    Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:286-297.
    PubMed     Text format     Abstract available


    April 2017
  47. BEHMENBURG F, Pickert E, Mathes A, Heinen A, et al
    The Cardioprotective Effect of Dexmedetomidine in Rats Is Dose-Dependent and Mediated by BKCa Channels.
    J Cardiovasc Pharmacol. 2017;69:228-235.
    PubMed     Text format     Abstract available


    March 2017
  48. ZHU A, Wei X, Zhang Y, You T, et al
    Propofol Provides Cardiac Protection by Suppressing the Proteasome Degradation of Caveolin-3 in Ischemic/Reperfused Rat Hearts.
    J Cardiovasc Pharmacol. 2017;69:170-177.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: